Literature DB >> 7046756

Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice.

Y Endo.   

Abstract

The injection of Escherichia coli lipopolysaccharide (LPS) into mice produced simultaneous induction of histidine and ornithine decarboxylases in the liver, lung, spleen and kidney. The time courses of the changes in activities of the two enzymes were similar in all the tissues. After the injection, both activities increased within 1.5 hr, peaked at 4.5 hr and returned to the basal levels within 15 hr. The induction of these enzymes was very sensitive to this agent, i.e. as little as 1 microgram/kg of the E. coli lipopolysaccharide produced significant increases in these enzyme activities. An increase in the product amines, histamine and putrescine, followed the rise of enzyme activities. The levels of histamine changed more rapidly than those of putrescine. In spite of the increase in putrescine, there was no increase in spermidine and spermine. In the brain and thymus the LPS induced ornithine decarboxylase, but not histidine decarboxylase. In the blood, the histamine level increased without an increase in the activity of histidine decarboxylase. These results are discussed in relation to the actions of lipopolysaccharide. A simple method for the simultaneous assay of the activities of histidine and ornithine decarboxylases without using radioisotope substrates was used in this study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046756     DOI: 10.1016/0006-2952(82)90394-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

Review 1.  Histamine H₄ receptors in the gastrointestinal tract.

Authors:  A Deiteren; J G De Man; P A Pelckmans; B Y De Winter
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells.

Authors:  Yasuhiro Nagai; Yukinori Tanaka; Toshinobu Kuroishi; Ryutaro Sato; Yasuo Endo; Shunji Sugawara
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Induction of histidine decarboxylase in skeletal muscle in mice by electrical stimulation, prolonged walking and interleukin-1.

Authors:  Y Endo; T Tabata; H Kuroda; T Tadano; K Matsushima; M Watanabe
Journal:  J Physiol       Date:  1998-06-01       Impact factor: 5.182

4.  Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.

Authors:  Y Endo; M Shibazaki; K Yamaguchi; K Kai; S Sugawara; H Takada; H Kikuchi; K Kumagai
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate.

Authors:  Y Endo; M Shibazaki; K Yamaguchi; M Nakamura; H Kosugi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo.

Authors:  Y Endo; M Nakamura; T Kikuchi; H Shinoda; Y Takeda; Y Nitta; K Kumagai
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

7.  Increase in histamine production by inflammatory exudate in the chronic phase of allergic inflammation in rats.

Authors:  N Hirasawa; M Shiraishi; S Oikawa; S Mue; K Ohuchi
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

8.  Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor.

Authors:  Y Endo; M Nakamura; Y Nitta; K Kumagai
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.

Authors:  Y Endo; T Kikuchi; M Nakamura
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Role of histamine in the antitumour activity of endotoxin.

Authors:  N Bloksma; P van de Wiel; F Hofhuis; F Kuper; J Willers
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.